Issue 8, 2025

In vitro and in vivo degradation studies of a dual medical-grade scaffold design for guided soft tissue regeneration

Abstract

Biodegradable scaffolds with tailored mechanical and structural properties are essential for scaffold-guided soft tissue regeneration (SGSTR). SGSTR requires scaffolds with controllable degradation and erosion characteristics to maintain mechanical and structural integrity and strength for at least four to six months. Additionally, these scaffolds must allow for porosity expansion to create space for the growing tissue and exhibit increased mechanical compliance to match the properties of the newly formed tissue. Although progress has been made in this area, previous studies have yet to fully explore these aspects using biodegradable polymers that are synthesized and 3D printed into filaments classified as medical-grade. In this study, we optimized scaffold design based on the properties of biodegradable materials and employed digital-assisted 3D printing to adjust the degradation pathway of dual-material scaffolds dynamically, thereby modulating mechanical and structural changes. Two medical-grade 3D printing filaments were utilized: Dioxaprene® (DIO), which has a degradation rate of approximately six months, and Caproprene™ (CAP), which has a degradation rate of about 36 months. The scaffolds were 3D printed with these materials to create the desired architecture. An in vitro degradation study showed the increasing pore size and compliance (>90% increase) of the scaffold architecture via the breakdown of DIO. Meanwhile, the slow-degrading CAP maintained long-term mechanical and structural integrity. Furthermore, over six months of subcutaneous implantation in rats, the dual material showed an approximately two-fold increase in mechanical compliance and free volume expansion, with the pore size increasing from 1 mm to 2 mm to accommodate the growing tissue. The scaffold remained structurally intact and provided mechanical support for the newly formed tissue. Histological and immunohistochemical analyses indicated good in vivo biocompatibility, tissue guidance, and the formation of organized soft tissue architecture, supported by an extensive network of blood vessels.

Graphical abstract: In vitro and in vivo degradation studies of a dual medical-grade scaffold design for guided soft tissue regeneration

Supplementary files

Article information

Article type
Paper
Submitted
27 Aug 2024
Accepted
05 Dec 2024
First published
10 Feb 2025

Biomater. Sci., 2025,13, 2115-2133

In vitro and in vivo degradation studies of a dual medical-grade scaffold design for guided soft tissue regeneration

M. Mohseni, S. Cometta, L. Klein, M. Wille, C. Vaquette, D. W. Hutmacher and F. Medeiros Savi, Biomater. Sci., 2025, 13, 2115 DOI: 10.1039/D4BM01132E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements